Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today | Read

PUBLISHED ON: June 22, 2021 | Duration: 2 min, 16 sec

  
loading..
Bharat Biotech has submitted Phase III trial data for the Covaxin coronavirus vaccine to the DCGI (Drug Controller General of India). The drug regulator's SEC (subject expert committee) is expected to meet around noon to discuss the results. The data has not yet been fully published in a recognised, peer-reviewed journal.
ALSO WATCH
भ्रष्टाचार के आरोपों के बीच भारत बायोटेक ने ब्राजील की 2 कंपनियों के साथ रद्द की डील

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com